| 3.195 -0.285 (-8.19%) | 11-11 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.55 | 1-year : | 5.19 |
| Resists | First : | 3.89 | Second : | 4.44 |
| Pivot price | 3.4  |
|||
| Supports | First : | 3 | Second : | 2.49 |
| MAs | MA(5) : | 3.26  |
MA(20) : | 3.51 |
| MA(100) : | 4.51 |
MA(250) : | 3.41 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 36.1 |
D(3) : | 28.1 |
| RSI | RSI(14): 39.7 |
|||
| 52-week | High : | 6.23 | Low : | 1.29 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SNES ] has closed above bottom band by 27.8%. Bollinger Bands are 34.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.56 - 3.58 | 3.58 - 3.59 |
| Low: | 3.42 - 3.44 | 3.44 - 3.46 |
| Close: | 3.45 - 3.48 | 3.48 - 3.5 |
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Tue, 11 Nov 2025
SenesTech (NASDAQ: SNES) adds Belize Raptor Center distributor following import approval - Stock Titan
Tue, 11 Nov 2025
SenesTech (SNES) Reports Record Q3 Revenues and Improved EBITDA - GuruFocus
Tue, 11 Nov 2025
SenesTech Inc (SNES) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion - Yahoo Finance
Mon, 10 Nov 2025
Earnings call transcript: SenesTech sees Q3 2025 revenue up 43%, stock rises - Investing.com UK
Mon, 10 Nov 2025
SenesTech, Inc. SEC 10-Q Report - TradingView
Mon, 10 Nov 2025
SenesTech (NASDAQ: SNES) lists Evolve Rat on Lowes.com; Lowe's $11B online, 1,700 stores - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals - Specialty
|
|
| Shares Out | 5 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 4.4 (%) |
| Held by Institutions | 2.2 (%) |
| Shares Short | 64 (K) |
| Shares Short P.Month | 96 (K) |
| EPS | -4.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.85 |
| Profit Margin | -289.1 % |
| Operating Margin | -258.3 % |
| Return on Assets (ttm) | -52.8 % |
| Return on Equity (ttm) | -119.9 % |
| Qtrly Rev. Growth | 36.2 % |
| Gross Profit (p.s.) | 0.25 |
| Sales Per Share | 0.4 |
| EBITDA (p.s.) | -1.15 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -0.75 |
| PEG Ratio | 0 |
| Price to Book value | 1.73 |
| Price to Sales | 7.97 |
| Price to Cash Flow | -3.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|